IMMUNOGLOBULIN-G ISOTYPE CHANGES IN HUMAN SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)

被引:7
|
作者
WESTARP, ME [1 ]
BARTMANN, P [1 ]
KORNHUBER, HH [1 ]
机构
[1] UNIV ULM,DEPT PEDIAT,D-89070 ULM,GERMANY
关键词
AMYOTROPHIC LATERAL SCLEROSIS; HUMAN SPUMA RETROVIRUS; IMMUNOGLOBULINS; IMMUNOGLOBULIN-G ISOTYPES; MOTOR NEURON DISEASE;
D O I
10.1016/0304-3940(94)90164-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Out of 50 patients with sporadic amyotrophic lateral sclerosis (sALS), excluding 8 patients with recent immunosuppressive medication or low total IgG, we examined all available 92 sera of 1 1 women and 31 men nephelometrically for serum immunoglobulin concentrations including IgG isotypes IgG(1-4). Mean serum levels of IgA and IgM remained within references in all cases. Isotypes IgG(1) and IgG(3) were the most frequently altered immunoglobulins. Without specific treatment, 34 out of 42 patients ( = 80%) and 58 out of 92 sera ( = 63%) demonstrated low IgG(3) concentrations ( < 0.41 g/l), while 14 patients ( = 33%) and 20 sera ( = 22%) demonstrated low IgG, serum levels ( < 4.22 g/l). In patients with normal total IgG, isotypes IgG, and IgG, often changed in a complementary way, and IgG(1)/IgG(2) serum concentrations correlated significantly (r(s) = -0.518, P < 0.001). In four longitudinally monitored patients, the IgG(3) isotype ranged from 1.3% to 8.2% of serum IgG and demonstrated a remarkable individual variability over time, corresponding to the relatively short half-life of IgG(3). Since elevated circulating immune complexes may fluctuate rapidly, altered serum immunoglobulin isotypes could become more convenient parameters in a still enigmatic disease. To assess their role and relevance, their association with clinical course, cerebrospinal fluid and circulating immune complexes has to be examined.
引用
收藏
页码:124 / 126
页数:3
相关论文
共 50 条
  • [1] THE INTERMEDIOLATERAL NUCLEUS IN SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS
    TAKAHASHI, H
    OYANAGI, K
    IKUTA, F
    ACTA NEUROPATHOLOGICA, 1993, 86 (02) : 190 - 192
  • [2] PATHOGENIC MECHANISMS IN SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS
    EISEN, A
    KRIEGER, C
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1993, 20 (04) : 286 - 296
  • [3] EPIDEMIOLOGIC CORRELATES OF SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS
    ARMON, C
    KURLAND, LT
    DAUBE, JR
    OBRIEN, PC
    NEUROLOGY, 1991, 41 (07) : 1077 - 1084
  • [4] CLARKES COLUMN IN SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS
    TAKAHASHI, H
    OYANAGI, K
    OHAMA, E
    IKUTA, F
    ACTA NEUROPATHOLOGICA, 1992, 84 (05) : 465 - 470
  • [5] MR EVALUATION OF AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)
    SHERMAN, JL
    CLAWSON, LL
    CITRIN, CM
    CORNBLATH, D
    KUNCL, R
    PESTRONK, A
    DRACHMAN, DB
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1987, 8 (05) : 941 - 941
  • [6] INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN AMYOTROPHIC-LATERAL-SCLEROSIS
    MITSUMOTO, H
    KUMAR, S
    LEVIN, KH
    SHIELDS, RW
    SECIC, M
    WILBOURN, AJ
    DESAI, RG
    ANNALS OF NEUROLOGY, 1992, 32 (02) : 252 - 252
  • [7] Sporadic and hereditary amyotrophic lateral sclerosis (ALS)
    Ajroud-Driss, Senda
    Siddique, Teepu
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (04): : 679 - 684
  • [8] ACCUMULATION OF NEUROFILAMENTS IN A SPORADIC CASE OF AMYOTROPHIC-LATERAL-SCLEROSIS
    KONDO, A
    IWAKI, T
    TATEISHI, J
    KIRIMOTO, K
    MORIMOTO, T
    OOMURA, I
    JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY, 1986, 40 (04): : 677 - 684
  • [9] HTLV INVOLVEMENT IN SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS - AN UPDATE
    FERRANTE, P
    WESTARP, ME
    MANCUSO, R
    PURICELLI, S
    ZUFFOLATO, MR
    WESTARP, MP
    CAPUTO, D
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S142 - S142
  • [10] AUTOIMMUNITY AS AN ETIOLOGIC FACTOR IN SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS
    APPEL, SH
    SMITH, RG
    ALEXIANU, MF
    ENGELHARDT, JI
    STEFANI, E
    PATHOGENESIS AND THERAPY OF AMYOTROPHIC LATERAL SCLEROSIS, 1995, 68 : 47 - 57